| |
| Magyar Laboratóriumi Diagnosztikai Társaság |
|
| 2nd EFLM Strategic Conference (Germany, Mannheim, 18-19 June 2018) |
 Rendezvény kezdete: 2018.06.18. | Rendezvény vége: 2018.06.19. |
| Szakterület(ek): Laboratóriumi medicina |
| Helyszín: Germany, Mannheim, |
Main topics:
The end of laboratory medicine as we know it? Handling
disruption of laboratory medicine in digital health
Invitation and scientific programme >>
The conference will consider the impact that the on-going digitalization of technologies and a digitalized society will have on the medical laboratory in future health care. We contend that such changes enable Digital Health that will be disruptive for Laboratory Medicine as we know it, because they will change our capabilities to compile, integrate and visualize complex diagnostic data as well as providing the opportunity for radical changes to diagnostic health strategies.
With the digital revolution spreading into every realm of modern medicine, we will experience a democratisation of health care, i.e. a comprehensive data usage not just being in the hands of health care professionals, but also in the patients´. Indeed, a central concept of digital health medicine is patient empowerment as demonstrated by key words like “electronic health record”, “patient access”, “health apps”, “wearable health tech” etc. In this rapidly changing health care environment, Laboratory Medicine must redefine its positions, not only acting in its classical role as provider of laboratory results, but also adopting new roles and responsibilities in the clinical dialogue.
|
|
|
 |
| |
| Magyar Laboratóriumi Diagnosztikai Társaság |
|
| 2nd EFLM Strategic Conference (Germany, Mannheim, 18-19 June 2018) |
| Rendezvény kezdete: 2018.06.18. | Rendezvény vége: 2018.06.19. |
| Szakterület(ek): Laboratóriumi medicina |
| Helyszín: Germany, Mannheim, |
Main topics:
The end of laboratory medicine as we know it? Handling
disruption of laboratory medicine in digital health
Invitation and scientific programme >>
The conference will consider the impact that the on-going digitalization of technologies and a digitalized society will have on the medical laboratory in future health care. We contend that such changes enable Digital Health that will be disruptive for Laboratory Medicine as we know it, because they will change our capabilities to compile, integrate and visualize complex diagnostic data as well as providing the opportunity for radical changes to diagnostic health strategies.
With the digital revolution spreading into every realm of modern medicine, we will experience a democratisation of health care, i.e. a comprehensive data usage not just being in the hands of health care professionals, but also in the patients´. Indeed, a central concept of digital health medicine is patient empowerment as demonstrated by key words like “electronic health record”, “patient access”, “health apps”, “wearable health tech” etc. In this rapidly changing health care environment, Laboratory Medicine must redefine its positions, not only acting in its classical role as provider of laboratory results, but also adopting new roles and responsibilities in the clinical dialogue.
|
|
|
|
| |
| Magyar Endokrinológiai és Anyagcsere Társaság |
|
| Heart, Vessels and Diabetes European Conference |
| Rendezvény kezdete: 2010.12.01. | Rendezvény vége: 2010.12.01. |
| Szakterület(ek): Endokrinológia, anyagcsere betegségek |
| Tudományos információ: Prof. Michel KOMAJDA |
| Címe: USA, |
| Munkahely neve: HVD 2010 - PLB. Organisation Inc. c/o Guibert & Co |
| Címe: USA, NY 10016 New York, 149 East 36th street |
| Helyszín: Portugal, Lisbon, Lisbon Congress Centre |
| A rendezvény Web oldala: http://www.hvd-euroconference.com |
On behalf of the Organising Committee, it is our distinct pleasure to announce the 1st edition of the Heart, Vessels & Diabetes European Conference to be held in the capital city of Portugal, Lisbon, from 9 to 11 December 2010.
Our world is facing an epidemic of diabetes and obesity, a population at high risk of cardiovascular complications. It is therefore necessary to promote in depth discussions and collaborations amongst all the professionals concerned by the management of these patients: cardiologists, diabetologists, endocrinologists, nephrologists, neurologists
and internists.
Our ambition is that the Heart, Vessels & Diabetes Conference becomes the European reference on both cardiovascular and diabetes related issues by the creation of a unified forum where all specialists will attend common sessions and share their experience. The scientific programme will include lectures, debates, clinical case presentations as well as industry symposia. European experts will discuss the latest developments of clinical trials and clinical research and will examine their implications for daily practice.
This event of very high scientific standard with a panel of European key opinion leaders will gather a large audience of about 2,000 practitioners in cardiology, diabetes, lipids, blood pressure and related fields. As you will read within this preliminary programme, the members of the Scientific Committee are among some of the most prestigious and renowned cardiologists, diabetologists and endocrinologists in order to ensure the highest scientific level to the sessions.
The Organising Committee of the 1st edition of the Heart, Vessels & Diabetes European Conference has appointed PLB. Organisation Inc. as the official Conference Office, entrusted with the handling of all conference related arrangements.
For any information, please do not hesitate to contact the Conference Office:
PLB. Organisation Inc.
hvd2010@agence-plb.com
Web: www.hvd-euroconference.com |
|
|
|
